Status:
COMPLETED
Combined Triple Therapy in Diabetic Retinopathy (DRP)
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Macular Edema
Diabetic Retinopathy
Eligibility:
All Genders
21+ years
Phase:
PHASE3
Brief Summary
The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with macular edema due to diabetic retinopathy.
Detailed Description
This prospective, monocenter pilot case series was conducted between May 2006 and November 2008. Patients were included because of DME and signs of pre- and early proliferation because of diabetic ret...
Eligibility Criteria
Inclusion
- Diagnosis of diabetic retinopathy
- macular edema more than 200 micron
- vitreous bleeding because of angiography documented NVEs NVDs, based on the definitions of ETDRS
Exclusion
- Prior intraocular injection within 4 months
- Core or complete vitrectomy
- History of glaucoma or ocular hypertension
- Presence of iris neovascularization
- Significant media opacity
- Monocularity and pregnancy
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00806169
Start Date
April 1 2006
End Date
November 1 2008
Last Update
September 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Vitreoretinal Surgery
Frankfurt am Main, Hesse, Germany, 60590